Tarsus Pharmaceuticals Inc (TARS)
EBITDA Margin
-7.29%
Quarterly · Period ending:
TARS EBITDA Margin
Latest reported-7.29%period ending
Latest reported-7.29%period ending
TARS Quarterly EBITDA Margin (0.00% → -7.29%)
Quarterly ebitda margin
High-resolution chart · PNG
TARS ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -7.2905% | |
| -4.1677% | |
| -2.4112% | |
| -10.2656% | |
| -17.1898% | |
| -28.6551% | |
| -30.6725% | |
| -43.0005% | |
| -75.8141% | |
| -124.857% | |
| -310.2325% | |
| -2,035.2218% | |
| 0% | |
| -906.4% | |
| -128.09% | |
| 0% | |
| -33.4293% | |
| -3,688.3117% | |
| -4,365.9763% | |
| -1,286.6935% | |
| 29.5181% | |
| 32.1638% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |